为了探索一种新的IL—2/LAK治疗方案,本研究采用rIL—2和自行设计的工艺制备的人同种异体LAK细胞,按“3W”方案,治疗多种晚期恶性肿瘤患者共38例.结果表明,多数患者自觉症状有改善,生活质量提高,部分患者的癌性症状改善明显,38例患者中,CR3例(7.9%),PR14例(36.8%).作者认为该疗法与国外同类方法相比,制备工艺简便,LAK细胞获取量大,治疗效果肯定,副作用轻,具有一定的推广应用价值. In order to explore a new IL-2/LAK treatment program, this study used rIL-2 and human-made allogeneic LAK cells prepared by a self-designed process to treat 38 patients with multiple advanced malignant tumors according to the “3W” protocol. The results showed that the majority of patients had improvement in their subjective symptoms and improved quality of life. Some of the patients had significantly improved cancer symptoms. Of the 38 patients, 3 were CR (7.9%), and 14 were PR (36.8%). The authors believe that the therapy is similar to foreign ones. Compared with the method, the preparation process is simple, the amount of LAK cells is large, the treatment effect is affirmative, the side effects are light, and has certain application value.